CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Leadman Biochemistry Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Leadman Biochemistry Co Ltd
No. 5 Xinghai Road
Beijing Economic and Tchnlgcl Dev Zn
Phone: +86 1084923554p:+86 1084923554 BEIJING, BEJ  100176  China Ticker: 300289300289
Business Summary
Beijing Leadman Biochemistry Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of in vitro diagnostic reagents. The Company's products primarily include four categories. The vitro diagnostic reagents include biochemical diagnostic reagents and immunodiagnostic reagents, and are mainly used for auxiliary diagnosis of diseases such as liver disease, kidney disease, cardiovascular disease, diabetes, immune disease, metabolic disease, pancreatitis, coagulation and fibrinolysis disorders. The diagnostic instrument products primarily include the CI 2000 S, CI1200, and CI1200 P series of fully automatic chemiluminescence immunoassays. The biochemical raw materials include enzymes, coenzymes, antigens, antibodies, and other reagents. The Company primarily conducts its businesses in domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3826 Laboratory analytical instruments
2836 Biological products, except diagnostic substances
6512 Operators of nonresidential buildings
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ZiYao 39 11/29/2024 11/29/2024
Acting President, Vice President YaoliangDing 49 3/15/2023 9/20/2016
Finance Director XuOuyang 40 4/13/2021 4/13/2021
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 468 (As of 12/31/2024)
Outstanding Shares: 544,011,487 (As of 9/30/2025)
Shareholders: 18,110
Stock Exchange: SHE
Fax Number: +86 1067856540


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, October 31, 2025